Non-invasive Prenatal Testing (NIPT) Market : Analysis and In-depth Study on Non-invasive Prenatal Testing (NIPT) Market Size Trends, Emerging Growth Factors and Forecasts to 2017 – 2025

Global Non-invasive Prenatal Testing (NIPT) market report

TMRR boasts its expertise by collecting 1.2 Mn+ data points every year in its data base. Our dedicated crew of experts are in consistent communication with relevant local distributors, and service providers to gather accurate industry-centric insights. We serve our clients day-and-night and offer reports tailored to the clients’ needs.

Analysts at TMRR, influenced by the potential, have published a report on the global Non-invasive Prenatal Testing (NIPT) market. As per the report, government support, rising consumption of Non-invasive Prenatal Testing (NIPT) , and enhanced purchasing capacity of consumers are characterizing the Non-invasive Prenatal Testing (NIPT) market is expected to grow at a CAGR of xx% over the forecast timeframe 2019-2029

Reports at discounted rate for early birds!!!

Request For Discount On This Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=2198&source=atm

growth drivers for the global non-invasive prenatal testing (NIPT) market. In addition to this number of babies born with Down syndrome, XYY syndrome, Turner, and Klinefelter is increasing, boosting the growth of the market. These chromosomal aneuploidies occur as a result of infertility, reproductive loss, and language development delays and can be detected and diagnosed by non-invasive prenatal testing. Thus, NIPT enables the detection of fatal chromosomal aneuploidies through the analysis of the cell-free DNA of fetuses. NIPT makes use of ultrasononography and serum screening. 

Global Non-invasive Prenatal Testing (NIPT) Market: Key Trends 

One in every 830 child births in the U.S. suffers from the Down syndrome, as per Down Syndrome Education (DSE). In Europe, the incidence rate for Down syndrome is one in every 920 babies. Thus, there exists a large potential consumer base for NIPT. An increasing number of people are preferring NIPT because chorionic villus sampling (CVS) and amniocentesis, which are the traditional invasive prenatal genetic tests can result in the risk of miscarriage. Non-invasive prenatal testing however, analyze the cell-free DNA, which floats in the maternal plasma. Thus, no risk of miscarriage exists in the use of NIPT methods. A growing number of doctors are opting for non-invasive prenatal testing that make use of cell-free circulating DNA in the maternal serum. 

Global Non-invasive Prenatal Testing (NIPT) Market: Market Potential 

Sequenom Inc., a key player operating in the NIPT market has recently announced the enhancement of MaterniT® GENOME laboratory-developed test that identifies 1 in 3 positive findings that may not be detected by standard NIPT. While standard NIPTs can identify chromosomal abnormalities such as trisomies 21,13, 18, and chromosome aneuploidies, the MaterniT® GENOME can analyze all chromosomes for gains and losses of chromosomal materials that are 7 Megabases or greater in size. In fact it can also analyze microdeletions, which are less than 7 Megabases.

Efforts such as this by key players are expected to create growth potential for the global non-invasive prenatal testing market. Furthermore, untapped markets in emerging nations are projected to offer growth opportunities to players in the NIPT market.

Global Non-invasive Prenatal Testing (NIPT) Market: Regional Outlook

While North America has been leading in the global non-invasive prenatal testing owing to the presence of key players in the U.S. coupled with high awareness levels about NIPT, Europe is anticipated to emerge second in terms of leading. Moreover, Asia Pacific is anticipated to be the region witnessing the fastest growth, with countries such as China, Australia, India, and Japan holding great potential for growth in the NIPT market. A growing number of women preferring late pregnancy in the region is anticipated to be the driving force for the growth of the Asia Pacific non-invasive prenatal market. BGI Diagnostics and Berry Genomics are two of the leading companies operating in the NIPT market in China, which has pushed the growth of country. Moreover, the CFDA approval for BambniTest has propelled the growth of the market in this region. 

Global Non-invasive Prenatal Testing (NIPT) Market: Competitive Landscape

Illumina, Inc. (Verinata Health, Inc.), Sequenom, Inc., Ariosa Diagnostics, BGI Health, Natera, Inc., LabCorp, LifeCodexx AG, and Berry Genomics are the key players competing in the non-invasive prenatal testing market. By forming alliances with physician offices, hospitals, and clinical laboratories, these players operate by marketing their proprietary non-invasive prenatal tests.

Request Sample Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2198&source=atm

The Non-invasive Prenatal Testing (NIPT) market research addresses the following queries:

  1. How does the global Non-invasive Prenatal Testing (NIPT) market looks like in the next decade?
  2. How is the competition of the global Non-invasive Prenatal Testing (NIPT) market distributed?
  3. Which end use segment will have the maximum share of the global Non-invasive Prenatal Testing (NIPT) market by the end of 2029?
  4. Which governing bodies have granted approval to the application of Non-invasive Prenatal Testing (NIPT) in xx industry?
  5. Which region currently holds the largest share of the global Non-invasive Prenatal Testing (NIPT) market?

What information does the Non-invasive Prenatal Testing (NIPT) market report consists of?

  • Production capacity of the Non-invasive Prenatal Testing (NIPT) market during the historic year as well as forecast year.
  • Basic overview of the Non-invasive Prenatal Testing (NIPT) , including definition, applications and manufacturing processes.
  • Scrutinization of the competitive landscape into market and regional penetration, acquisitions, and agreements with SWOT analysis.
  • Key regions holding significant share in the global Non-invasive Prenatal Testing (NIPT) market alongwith the important countries.
  • Accurate Year-on-Year growth of the global Non-invasive Prenatal Testing (NIPT) market.

Customize This Report @ https://www.tmrresearch.com/sample/sample?flag=CR&rep_id=2198&source=atm

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in today’s supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This post was originally published on Analytics News